EP-1245: Gated Rapidarc using KV intrafraction verification for liver stereotactic treatment
نویسندگان
چکیده
منابع مشابه
Prostate Intrafraction Motion Assessed by Simultaneous Kv
PROSTATE INTRAFRACTION MOTION ASSESSED BY SIMULTANEOUS KV FLUOROSCOPY AT MV DELIVERY by JUSTUS D. ADAMSON August 2009 Co-Advisor: Dr. Qiuwen Wu Co-Advisor: Dr. Jay Burmeister Major: Medical Physics Degree: Doctor of Philosophy Purpose: To investigate the use of a gantry mounted kV imager for prostate intrafraction motion measurement during simultaneous dose delivery. Materials & Methods: We dev...
متن کاملDosimetric verification of RapidArc treatment delivery.
PURPOSE Recently, Varian Medical Systems have announced the introduction of a new treatment technique, in which dose is delivered over a single gantry rotation with variable MLC positions, dose rate and gantry speed. In February 2008, a preclinical installation of the RapidArc beam delivery approach was carried out on a Varian Clinac at Rigshospitalet in Copenhagen. The purpose of the installat...
متن کاملRoutine verification of RapidArc ® plans using Epiqa TM
Epiqa TM is a program that allows to convert a dosimetric image acquired by an EPID into a dosemap and to compare the dosemap with a reference dose distribution. It is possible to utilize Epiqa for a verification of static as well as intensity modulated fields, including RapidArc ® fields. This text attempts to provide an overview of applied principles, describe the workflow, and discuss obtain...
متن کاملDosimetric impact of interplay effect on RapidArc lung stereotactic treatment delivery.
PURPOSE Volumetric modulated arc therapy (RapidArc; Varian Medical Systems, Palo Alto, CA) allows fast delivery of stereotactic radiotherapy for Stage I lung tumors. We investigated discrepancies between the calculated and delivered dose distributions, as well as the dosimetric impact of leaf interplay with breathing-induced tumor motion. METHODS AND MATERIALS In 20 consecutive patients with ...
متن کاملStereotactic Radiotherapy for Liver Metastases
Liver metastases are common in oncologic patients, causing substantial morbidity and mortality. Systemic therapy is now standard palliative treatment for most patients with liver metastases, often providing transient responses and increased overall survival. In selected oligometastatic patients, local treatment can lead to long disease-free intervals and even permanent disease control. Although...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Radiotherapy and Oncology
سال: 2013
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(15)33551-9